Results from a phase 1 study investigating the safety and pharmacokinetics of the aldosterone synthase inhibitor baxdrostat in subjects with varying degrees of hepatic function

被引：0
|
作者：
Hui, James [1 ]
Halvorsen, Yuan-Di [1 ]
Bond, Mary [2 ]
Murphy, Brian [2 ]
Isaacsohn, Jonathan [2 ]
Freeman, Mason W. [1 ]
机构：
[1] CinCor Pharma Inc, Waltham, MA USA
[2] CinRx Pharma LLC, Cincinnati, OH USA
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0061
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [1] Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function
    Freeman, Mason W.
    Halvorsen, Yuan-Di
    Bond, Mary
    Murphy, Brian
    Isaacsohn, Jonathan
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (04): : 410 - 418
  • [2] Results From a Phase 1 Study Demonstrating the Safety and Pharmacokinetics of the Aldosterone Synthase Inhibitor CIN-107 in Subjects With Varying Degrees of Renal Function
    Freeman, Mason W.
    Halvorsen, Yuan-Di
    Bond, Mary
    Murphy, Brian
    Isaacsohn, Jonathan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 527 - 528
  • [3] Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension
    Awosika, Ayoola
    Cho, Yoonje
    Bose, Ujjal
    Omole, Adekunle E.
    Adabanya, Uzochukwu
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (11) : 985 - 995
  • [4] PHARMACOKINETICS AND SAFETY OF TIAGABINE IN SUBJECTS WITH VARYING DEGREES OF HEPATIC-FUNCTION
    GUSTAVSON, LE
    QIAN, JX
    SAULIS, R
    CARLSON, GF
    LAU, A
    SPERELAKIS, R
    LAM, N
    RINGHAM, GL
    SOMMERVILLE, KW
    EPILEPSIA, 1995, 36 : S159 - S159
  • [5] Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
    Freeman, Mason W.
    Bond, Mary
    Murphy, Brian
    Hui, James
    Isaacsohn, Jonathan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (03) : 277 - 286
  • [6] Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers
    Freeman, Mason W.
    Bond, Mary
    Murphy, Brian
    Hui, James
    Isaacsohn, Jonathan
    HYPERTENSION RESEARCH, 2023, 46 (01) : 108 - 118
  • [7] Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers
    Mason W. Freeman
    Mary Bond
    Brian Murphy
    James Hui
    Jonathan Isaacsohn
    Hypertension Research, 2023, 46 : 108 - 118
  • [8] Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects
    Mason W. Freeman
    Mary Bond
    Brian Murphy
    James Hui
    Jonathan Isaacsohn
    American Journal of Cardiovascular Drugs, 2023, 23 : 277 - 286
  • [9] PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY RESULTS FROM A PHASE 1 MULTIPLE ASCENDING DOSE STUDY OF THE SELECTIVE ALDOSTERONE SYNTHASE INHIBITOR CIN-107
    Freeman, Mason W.
    Bond, Mary
    Murphy, Brian
    Hui, James
    Isaacson, Jonathan
    JOURNAL OF HYPERTENSION, 2023, 41 : E42 - E43
  • [10] Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function
    Lau, AH
    Gustavson, LE
    Sperelakis, R
    Lam, NP
    ElShourbagy, T
    EPILEPSIA, 1997, 38 (04) : 445 - 451
12345